Rchr
J-GLOBAL ID：202201016477786582
Update date: Feb. 01, 2024
Matsumoto Toshihide
マツモト トシヒデ | Matsumoto Toshihide
Affiliation and department：
Job title：
Junior Associate Professor
Research field (1)：
Human pathology
Research theme for competitive and other funds (5)：
- 2020 - 2024 滑膜下結合組織の線維化機構に着眼した透析患者における手根管症候群発症機序の解明
- 2020 - 2023 卵巣明細胞癌の抗癌剤耐性関連新規バイオマーカー:EBP50の同定とその機能解析
- 2020 - 2023 がん幹細胞発生でのAktシグナル経路によるエピゲノム制御と代謝制御の解明
- 2017 - 2021 TGFbeta-mediated LEFTY/Akt/GSK-3beta/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas
- 2014 - 2017 Identification of LEFTY as a molecular marker for ovarian clear cell carcinoma: its relationship to apoptosis and cell proliferation
Papers (39)：
-
Mayu Nakagawa, Toshihide Matsumoto, Ako Yokoi, Miki Hashimura, Yasuko Oguri, Ryo Konno, Yu Ishibashi, Takashi Ito, Kensuke Ohhigata, Yohei Harada, et al. Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma. Molecular oncology. 2023
-
Yui Kobayashi, Ako Yokoi, Miki Hashimura, Yasuko Oguri, Ryo Konno, Toshihide Matsumoto, Masataka Tochimoto, Mayu Nakagawa, Yu Ishibashi, Takashi Ito, et al. Nucleobindin-2 Mediates Transforming Growth Factor-β1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma. The American journal of pathology. 2023. 193. 8. 1116-1128
-
Akemi Inoue, Toshihide Matsumoto, Yuka Ito, Makoto Saegusa, Hiroyuki Takahashi. TP53 positivity combined with high fibrinogen expression defines a subtype of oral squamous cell carcinoma with an unfavorable prognosis. Human pathology. 2022. 130. 25-35
-
Ako Yokoi, Marina Minami, Miki Hashimura, Yasuko Oguri, Toshihide Matsumoto, Yoshinori Hasegawa, Mayu Nakagawa, Yu Ishibashi, Takashi Ito, Kensuke Ohhigata, et al. PTEN overexpression and nuclear β-catenin stabilization promote morular differentiation through induction of epithelial-mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma. Cell communication and signaling : CCS. 2022. 20. 1. 181-181
-
Hiroyuki Takahashi, Hirono Watanabe, Miki Hashimura, Toshihide Matsumoto, Ako Yokoi, Mayu Nakagawa, Yu Ishibashi, Takashi Ito, Kensuke Ohhigata, Makoto Saegusa. A combination of stromal PD-L1 and tumoral nuclear β-catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma. The journal of pathology. Clinical research. 2022. 8. 5. 458-469
ｍore...
MISC (2)：
-
Kobayashi Makoto, Matsumoto Toshihide, Nagashio Ryo, Yanagita Kengo, Ryuge Shinichiro, Shi-Xu Jiang, Saegusa Makoto, Sato Yuichi. Utility of CAXII as a novel sero-diagnostic marker in patients with lung cancer. Abstracts for Annual Meeting of Japanese Proteomics Society. 2011. 2011. 167-167
-
大西 美帆子, 松本 俊英, 川島 祐介, 長塩 亮, 影山 泰平, 小寺 義男, 佐藤 雄一. 肺癌静脈血を用いた腫瘍マーカーの獲得. 日本病理学会会誌. 2008. 97. 1. 393-393
Patents (3)：
Return to Previous Page
